About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming treatments for central nervous system (CNS) disorders. We are committed to bridging critical care gaps with innovative and unique products that focus on novel mechanisms of action, leading to significant improvements in patient outcomes. Our extensive neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness related to narcolepsy and obstructive sleep apnea, and migraine, alongside multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions affecting over 150 million individuals in the United States. Our mission is clear: to tackle some of the most pressing challenges faced by the brain, enabling patients and their families to thrive.

